Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Petr Cetkovský"'
Autor:
Šárka Šestáková, Cyril Šálek, Dávid Kundrát, Ela Cerovská, Jan Vydra, Ivana Ježíšková, Adam Folta, Jiří Mayer, Petr Cetkovský, Hana Remešová
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-12 (2024)
Abstract Background Changes in DNA methylation are common events in the pathogenesis of acute myeloid leukemia (AML) and have been repeatedly reported as associated with prognosis. However, studies integrating these numerous and potentially prognosti
Externí odkaz:
https://doaj.org/article/445a337be93740f6998ac1681e644cb8
Autor:
Hana Klamová, Kateřina Machová Poláková, Jan Mužík, Zdeněk Ráčil, Daniela Žáčková, Kateřina Steinerová, Michal Karas, Edgar Faber, Eva Demečková, Zuzana Michalovičová‐Sninská, Jaroslava Voglová, Ľudmila Demitrovičová, Eva Mikušková, Elena Tóthová, Juraj Chudej, Imrich Markuljak, Eduard Cmunt, Jana Moravcová, Dana Dvořáková, Kyra Michalová, Marie Jarošová, Markéta Marková Šťastná, Petr Cetkovský, Ladislav DuŠek, Vladimír Koza, Marek Trněný, Karel Indrák
Publikováno v:
Cancer Medicine, Vol 2, Iss 2, Pp 216-225 (2013)
Abstract We evaluated responses to the treatment and long‐term outcomes of chronic myeloid leukemia patients treated with imatinib as first‐line treatment in routine clinical setting from two countries with centralized tyrosine kinase inhibitors
Externí odkaz:
https://doaj.org/article/3352c3f69ea544aab068556ac3c96068
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127637 (2015)
Nucleophosmin 1 (NPM1) mutations are frequently found in patients with acute myeloid leukemia (AML) and the newly generated sequences were suggested to induce immune response contributing to the relatively favorable outcome of patients in this AML su
Externí odkaz:
https://doaj.org/article/90857995ff54412c960d9fd003e65320
Autor:
Barbora Weinbergerová, Ivo Demel, Benjamin Víšek, Jan Válka, Martin Čerňan, Pavel Jindra, Jan Novák, Lukáš Stejskal, Flóra Kovácsová, Tomáš Kabut, Tomáš Szotkowski, Roman Hájek, Pavel Žák, Petr Cetkovský, Zdeněk Král, Jiří Mayer
Publikováno v:
Hematological Oncology. 40:280-286
COVID-19 significantly impairs survival rates among hematological patients when compared to the general population. Our prospective multicentre project analyzed early administration of anti-SARS-CoV-2 spike protein neutralizing monoclonal antibodies
Autor:
Štěpán Hrabovský, Cyril Šálek, Pavla Pecherkova, Petr Cetkovský, Hana Jelínková, Eva Froňková, František Folber, Michael Doubek, Jiří Mayer, Jan Trka, Jan M. Horáček
Publikováno v:
British Journal of Haematology. 196:706-710
The aim of the present study was to evaluate the significance of low-level minimal/measurable residual disease (MRD) during early consolidation treatment in adult BCR-ABL1-negative acute lymphoblastic leukaemia. The MRD load was monitored by immunogl
Autor:
Jan Vydra, Veronika Valkova, Markéta Š ťastná Marková, Antonin Vitek, Ludmila Nováková, Mariana Koubová, Barbora Čemusová, Petr Cetkovský
Publikováno v:
Transplantation and Cellular Therapy. 29:S280
Autor:
Šárka Šestáková, Ela Cerovská, Cyril Šálek, Dávid Kundrát, Ivana Ježíšková, Adam Folta, Jiří Mayer, Zdeněk Ráčil, Petr Cetkovský, Hana Remešová
Publikováno v:
Clinical Epigenetics. 14
Background Multiple studies have reported the prognostic impact of DNA methylation changes in acute myeloid leukemia (AML). However, these epigenetic markers have not been thoroughly validated and therefore are still not considered in clinical practi
Autor:
Michal Kolář, Petr Cetkovský, Cyril Šálek, Marketa Markova, Milena Vrana, L. Nováková, Veronika Valkova, Robert Pytlik, Petr Lesný, Jan Vydra, Barbora Čemusová, Antonin Vitek, Petr Soukup
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:365-371
Introduction Survival rate of patients with chemorefractory acute myeloid leukemia (AML) or myelodysplastic syndrome with excess blasts (MDS-EB) is poor. Allogeneic hematopoietic cell transplantation (HCT) is the only potentially curative therapy in
Autor:
Petr Cetkovský, Šárka Šestáková, Hana Remešová, Cyril Šálek, Zdeněk Krejčík, Zdeněk Ráčil, Pavla Pecherkova, Adam Folta, Jiří Mayer, Michaela Dostalova Merkerova, Ela Cerovska
Publikováno v:
Cancer Biomarkers. 25:43-51
Background Aberrant epigenetic patterns are a hallmark of acute myeloid leukemia (AML). Mutations in profound epigenetic regulators DNMT3A and IDH1/2 often occur concurrently in AML. Objectives The aim was to analyze DNA methylation, hydroxymethylati
Autor:
Jiří Schwarz, Cyril Šálek, Jan Novák, Zdeněk Ráčil, Pavla Pecherková, Jan Vydra, Jiří Mayer, Petr Cetkovský, Veronika Petečuková, Pavel Žák
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:106-113
Background We retrospectively analyzed data from 310 patients with acute myeloid leukemia with intermediate-risk cytogenetics in first complete remission (CR1) to evaluate the usage and efficacy of various types of postremission therapy. Patients and